Skip to main content
Log in

Thyrotoxicosis due to metastatic papillary thyroid cancer in a patient with Graves’ disease

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Thyrotoxicosis resulting from functional thyroid cancer metastases is extremely rare, and is mostly caused by follicular cancer. The lesions causing thyrotoxicosis are usually bulky and extensive. We report here a patient with Graves’ disease and concomitant papillary thyroid cancer who developed metastases causing symptomatic thyrotoxicosis. His serum titers of thyroid stimulating Ig (TSIs) were elevated. We believe that TSIs were responsible for thyrotoxicosis by stimulating hormonogenesis in the metastatic lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Belfiore A., Garofalo M.R., Giuffrida D., et al. Increased aggressiveness of thyroid cancer in patients with Graves’ disease. J. Clin. Endocrinol. Metab. 1990, 70: 830–835.

    Article  PubMed  CAS  Google Scholar 

  2. Pellegriti G., Belfiore A., Giuffrida D., Lupo L., Vigneri R. Outcome of differentiated thyroid cancer in Graves’ patients. J. Clin. Endocrinol. Metab. 1998, 83: 2805–2809.

    PubMed  CAS  Google Scholar 

  3. Clark O.H. TSH suppression in the management of thyroid nodules and thyroid cancer. World J. Surg. 1981, 5: 39–47.

    Article  PubMed  CAS  Google Scholar 

  4. Mazzaferri E.L. Thyroid cancer and Graves’ disease. J. Clin. Endocrinol. Metab. 1990, 70: 826–829.

    Article  PubMed  CAS  Google Scholar 

  5. Paul S.J., Sisson J.C. Thyrotoxicosis caused by thyroid cancer. Endocrinol. Metab. Clin. North Am. 1990, 19: 593–612.

    PubMed  CAS  Google Scholar 

  6. Oppenheim A., Miller M., Anderson G.H. Jr, Davis B., Slagle T. Anaplastic thyroid cancer presenting with hyperthyroidism. Am. J. Med. 1983, 75: 702–704.

    Article  PubMed  CAS  Google Scholar 

  7. Edmonds C.J., Thompson B.D. Hyperthyroidism induced by secondary carcinoma in the thyroid. Clin. Endocrinol. (Oxf.) 1978, 8: 411–415.

    Article  CAS  Google Scholar 

  8. Shimaoka K., VanHerle A.J., Dindogru A. Thyrotoxicosis secondary to involvement of the thyroid with malignant lymphoma. J. Clin. Endocrinol. Metab. 1976, 43: 64–68.

    Article  PubMed  CAS  Google Scholar 

  9. Filetti S., Belfiore A., Amir S.M., et al. The role of thyroidstimulating antibodies of Graves’ disease in differentiated thyroid cancer. N. Engl. J. Med. 1988, 318: 753–759.

    Article  PubMed  CAS  Google Scholar 

  10. Basaria S., Cooper D.S. Graves’ disease and recurrent ectopic thyroid tissue. Thyroid. 1999, 9: 1261–1264.

    Article  PubMed  CAS  Google Scholar 

  11. Kasagi K., Takeuchi R., Miyamoto S., et al. Metastatic thyroid cancer presenting as thyrotoxicosis: report of three cases. Clin. Endocrinol. (Oxf.) 1994, 40: 429–434.

    Article  CAS  Google Scholar 

  12. Studer H., Veraguth P., Wyss F. Thyrotoxicosis due to a solitary hepatic metastasis of thyroid carcinoma. J. Clin. Endocrinol. Metab. 1961, 21: 1334.

    Article  PubMed  CAS  Google Scholar 

  13. Valenta L., Lemarchand-Beraud T., Nemec J., Griessen M., Bednar J. Metastatic thyroid carcinoma provoking hyperthyroidism, with elevated circulating thyrostimulators. Am. J. Med. 1970, 48: 72–76.

    Article  PubMed  CAS  Google Scholar 

  14. Snow M.H., Davies T., Smith B.R., et al. Thyroid stimulating antibodies and metastatic thyroid carcinoma. Clin. Endocrinol. (Oxf.) 1979, 10: 413–418.

    Article  CAS  Google Scholar 

  15. Girelli M.E., Casara D., Rubello D., Pelizzo M.R., Busnardo B., Ziliotto D. Severe hyperthyroidism due to metastatic papillary thyroid carcinoma with favorable outcome. J. Endocrinol. Invest. 1990, 13: 333–337.

    PubMed  CAS  Google Scholar 

  16. Davies T.F., Roti E., Braveman L.E., Degroot L.J. Thyroid controversy-stimulating antibodies. J. Clin. Endocrinol. Metab. 1998, 83: 3777–3785.

    Article  PubMed  CAS  Google Scholar 

  17. Saravanan P., Dayan C. Thyroid autoantibodies. Endocrinol. Metab. Clin. North Am. 2001, 30: 315–337.

    Article  PubMed  CAS  Google Scholar 

  18. Cerletty J.M., William W.J. Hyperthyroidism due to functioning metastatic thyroid carcinoma. Precipitation of thyroid storm with therapeutic radioactive iodine. J.A.M.A. 1979, 242: 269–270.

    Article  PubMed  CAS  Google Scholar 

  19. Lorberboym M., Mechanick J.I. Accelerated thyrotoxicosis induced by iodinated contrast media in metastatic differentiated thyroid carcinoma. J. Nucl. Med. 1996, 37: 1532–1535.

    PubMed  CAS  Google Scholar 

  20. Nicoloff J.T., Low J.C., Dussault J.H., Fisher D.A. Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man. J. Clin. Invest. 1972, 51: 473–483.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  21. Sisson J.C., Carey J.E. Thyroid carcinoma with high levels of function: treatment with 131I. J. Nucl. Med. 2001, 42: 975–983.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Salvatori.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Basaria, S., Salvatori, R. Thyrotoxicosis due to metastatic papillary thyroid cancer in a patient with Graves’ disease. J Endocrinol Invest 25, 639–642 (2002). https://doi.org/10.1007/BF03345090

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345090

Key words

Navigation